Dihydroergotamine Mesylate Spray
Product Images NDC 68682-357

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Dihydroergotamine Mesylate (NDC 68682-357). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Oceanside Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1

This is a graph showing the estimated probability of a patient responding to a study medication (Dihydroergotamine Mesylate Nasal Spray) during the first four hours following a single 2mg dose. The graph shows the percentage probability of response for each hour since the start of treatment, based on data from two studies involving 208 patients receiving Dihydroergotamine Mesylate and 200 receiving a placebo.*

FDA Label Image

Figure 2

This is a graph that shows the estimated probability of a patient responding to Dihydroergotamine Mesylate Nasal Spray within the first four hours of dosing. The graph has a scale from 0 to 100 on the y-axis, indicating the percentage of probability, and a time scale in hours on the x-axis. The graph is taken from Studies 3 and 4 and involves 87 patients who received Dihydroergotamine Mesylate and 100 patients who received a placebo.*

FDA Label Image

Figure 3

This is a graphical representation showing the estimated probability of patients using additional treatments for migraine over 24 hours following either dihydroergotamine mesylate nasal spray 2 mg or placebo. The probability is shown on the y-axis and ranges from 0% to 100%, while the x-axis shows the time in hours after the first spray. The graph is based on data from 305 patients who received dihydroergotamine mesylate and 300 who received placebo.*

FDA Label Image

Image 01

The text appears to be a mixture of instructions and information regarding a nasal spray called "Dihydroergotamine Mesylate". It warns against injection and states that the spray is for nasal use only. The spray contains dextrose, purified water, and Anhydrous S0mg. It also includes a package insert and administration instructions. There is no clear indication of the purpose or use of the nasal spray beyond these details.*

FDA Label Image

Chemical Structure (Migranal 01)

Dihydroergotamine mesylate is a chemical compound with a molecular weight of 679.80. The chemical formula is Ca3H37N505.CH404S. The rest of the text appears to be non-English characters and cannot be evaluated.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.